WebMD8d
What to Know About the New Nasal Spray for Tough Depression
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Pharm Exec6d
Spravato’s Transformative Impact: Offering Hope and Rapid Relief for Patients with Depression
She told me that she didn’t know it was possible to feel this good, saying that it wasn’t until she took Spravato that she realized she didn’t have to walk in the fog anymore. Full Interview Summary: ...
Longview News-Journal15d
SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression
"SPRAVATO ® is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily oral ...